Literature DB >> 25742908

Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma.

Supriya Srivastava1, Bhavin Thakkar, Khay Guan Yeoh, Khek Yu Ho, Ming Teh, Richie Soong, Manuel Salto-Tellez.   

Abstract

In the development and progression of hepatocellular carcinoma, tumor hypoxia plays an important role, as does activation of the Wnt pathway. The aim of this study was to characterize the expression and interrelationship between hypoxia and Wnt-pathway-associated proteins as prognostic factors for hepatocellular carcinoma. Expression of HIF-1α, CA-IX, E-cadherin, β-catenin, and Ki-67 was assessed by immunohistochemistry in 179 primary hepatocellular carcinoma cases. Univariate and multivariate analyses were performed to assess the relationship between the clinicopathological factors, protein expression, overall survival (OS), and recurrence-free survival (RFS). By univariate analysis, tumor stage, size, satellitosis, and vascular invasion were confirmed as prognostic factors for worse OS and RFS. High expression of HIF-1α, CA-IX, β-catenin, Ki-67, and E-cadherin was observed in 60, 15, 64, 8, and 64 % of tumors, respectively, and this was significantly associated with poor OS. CA-IX, HIF-1α, and E-cadherin were independent predictors of poor prognosis. We stratified 169 patients into four groups according to the expression level of hypoxia and Wnt pathway markers. The group with high expression of both hypoxia and Wnt-pathway-associated proteins showed worst OS. The poor survival of this group was also significant in patients with early stage disease and tumor size of less than 5 cm (p < 0.05). We identified a subgroup of hepatocellular carcinoma patients with high expression of both hypoxia and Wnt pathway proteins and found this predictive of poor survival. The therapeutic options for this group might need to be revisited.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25742908     DOI: 10.1007/s00428-015-1745-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  42 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Long-term outcome of resection of large hepatocellular carcinoma.

Authors:  X-P Chen; F-Z Qiu; Z-D Wu; Z-W Zhang; Z-Y Huang; Y-F Chen
Journal:  Br J Surg       Date:  2006-05       Impact factor: 6.939

3.  Wnt-β-catenin signaling protects against hepatic ischemia and reperfusion injury in mice.

Authors:  Nadja Lehwald; Guo-Zhong Tao; Kyu Yun Jang; Michael Sorkin; Wolfram T Knoefel; Karl G Sylvester
Journal:  Gastroenterology       Date:  2011-05-04       Impact factor: 22.682

4.  A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.

Authors:  Ivraym B Barsoum; Chelsea A Smallwood; D Robert Siemens; Charles H Graham
Journal:  Cancer Res       Date:  2013-12-13       Impact factor: 12.701

5.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  A carbonic anhydrase inhibitor as a potential modulator of cancer therapies.

Authors:  B A Teicher; S D Liu; J T Liu; S A Holden; T S Herman
Journal:  Anticancer Res       Date:  1993 Sep-Oct       Impact factor: 2.480

7.  The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein.

Authors:  Huahong Xie; Jiugang Song; Kaige Liu; Hongzan Ji; Huiqin Shen; Shengjuan Hu; Guitao Yang; Yulei Du; Xue Zou; Haifeng Jin; Li Yan; Jie Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

8.  Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.

Authors:  J Saarnio; S Parkkila; A K Parkkila; K Haukipuro; S Pastoreková; J Pastorek; M I Kairaluoma; T J Karttunen
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

Review 9.  From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.

Authors:  Roberta W C Pang; Ronnie T P Poon
Journal:  Oncology       Date:  2007-12-13       Impact factor: 2.935

10.  A morpho-molecular prognostic model for hepatocellular carcinoma.

Authors:  S Srivastava; K F Wong; C W Ong; C Y Huak; K G Yeoh; M Teh; J M Luk; M Salto-Tellez
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

View more
  9 in total

Review 1.  Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Yihuan Luo; Fanghui Ren; Yongru Liu; Zhenhong Shi; Zhong Tan; Huojie Xiong; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 3.  The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues.

Authors:  Anna Sebestyén; Titanilla Dankó; Dániel Sztankovics; Dorottya Moldvai; Regina Raffay; Catherine Cervi; Ildikó Krencz; Viktória Zsiros; András Jeney; Gábor Petővári
Journal:  Cancer Metastasis Rev       Date:  2022-01-14       Impact factor: 9.264

4.  Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis.

Authors:  Yaobang Wang; Xi Wang; Xiaoliang Huang; Jie Zhang; Junwen Hu; Yapeng Qi; Bangde Xiang; Qiuyan Wang
Journal:  J Cancer       Date:  2021-03-19       Impact factor: 4.207

5.  HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy.

Authors:  Shaima Salman; David J Meyers; Elizabeth E Wicks; Sophia N Lee; Emmanuel Datan; Aline M Thomas; Nicole M Anders; Yousang Hwang; Yajing Lyu; Yongkang Yang; Walter Jackson; Dominic Dordai; Michelle A Rudek; Gregg L Semenza
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

Review 6.  Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis.

Authors:  Simon J A van Kuijk; Ala Yaromina; Ruud Houben; Raymon Niemans; Philippe Lambin; Ludwig J Dubois
Journal:  Front Oncol       Date:  2016-03-29       Impact factor: 6.244

7.  Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice.

Authors:  Harshul Pandit; Yan Li; Qianqian Zheng; Wei Guo; Youxi Yu; Suping Li; Robert C G Martin
Journal:  Oncotarget       Date:  2020-06-02

8.  Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.

Authors:  Philip Dao Trong; Saskia Rösch; Heimo Mairbäurl; Stefan Pusch; Andreas Unterberg; Christel Herold-Mende; Rolf Warta
Journal:  Int J Mol Sci       Date:  2018-09-25       Impact factor: 5.923

9.  Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.

Authors:  Carolina Méndez-Blanco; Paula Fernández-Palanca; Flavia Fondevila; Javier González-Gallego; José L Mauriz
Journal:  Ther Adv Med Oncol       Date:  2021-02-07       Impact factor: 8.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.